Pharma & Biotech Market Research

In this section you will find information products, including market research reports, on the following sector: Pharma & Biotech

Stay up-to-date with new products added to this category

Results 501 - 600 of 5395 go to 1st page

first

previous 1 2 3 4 5 6 7 8 9 10 11 next

last

Title	Date	Price
Kwang-Dong Pharmaceutical Co., Ltd-Company Report	Sep 2009	£455
Kuros Biosurgery AG-Company Report	Sep 2009	£455
Kwizda Pharma GmbH-Company Report	Sep 2009	£455
Kyorin Co., Ltd.-Company Report	Sep 2009	£455
Kyosei Pharmaceutical Co., Ltd.-Company Report	Sep 2009	£455
Kureha Corporation (formerly Kureha Chemical Industry Co., Ltd.)-Company Report	Sep 2009	£455
KunWha Pharmaceutical Co., Ltd.-Company Report	Sep 2009	£455
Krenitsky Pharmaceuticals Inc.-Company Report	Sep 2009	£455
Krka, d. d.-Company Report	Sep 2009	£455
Kuhnil Pharmaceutical Co., Ltd.-Company Report	Sep 2009	£455
KUKJE PHARMA IND CO LTD-Company Report	Sep 2009	£455
Kyoto Pharmaceutical Industries-Company Report	Sep 2009	£455
Kyowa Hakko Kirin Co., Ltd. (formerly Kyowa Hakko Kogyo Co., Ltd.)-Company Report	Sep 2009	£455
Laboratoires SMB-Company Report	Sep 2009	£455
Laboratoires Thea-Company Report	Sep 2009	£455
Laboratoires URGO S.A-Company Report	Sep 2009	£455
Laboratoires Carilene-Company Report	Sep 2009	£455
Laboratori Guidotti SpA-Company Report	Sep 2009	£455
Laboratoires Pierre Fabre SA-Company Report	Sep 2009	£455
Laboratoire Innotech International-Company Report	Sep 2009	£455
Kythera Biopharmaceuticals, Inc.-Company Report	Sep 2009	£455
Kyung Dong Pharma. Co., Ltd.-Company Report	Sep 2009	£455
Labima-Company Report	Sep 2009	£455
Laborate Pharmaceuticals India Ltd-Company Report	Sep 2009	£455
Kowa Pharmaceuticals America, Inc., (formerly ProEthic Pharmaceuticals, Inc.)-Company Report	Sep 2009	£455
Kowa Company, Ltd.-Company Report	Sep 2009	£455
Kedrion S.p.A-Company Report	Sep 2009	£455
Karo Bio AB-Company Report	Sep 2009	£455
Kee Pharma Ltd.-Company Report	Sep 2009	£455
Kemin Industries, Inc.-Company Report	Sep 2009	£455
Kenta Biotech Ltd.-Company Report	Sep 2009	£455
KARNATAKA ANTIBIOTICS AND PHARMACEUTICALS LIMITED-Company Report	Sep 2009	£455
Kamron Laboratories Ltd.-Company Report	Sep 2009	£455
KAKETSUKEN-Company Report	Sep 2009	£455
KaloBios Pharmaceuticals, Inc.-Company Report	Sep 2009	£455
Kalypsys, Inc.-Company Report	Sep 2009	£455
Kamada Ltd.-Company Report	Sep 2009	£455
Kereos, Inc-Company Report	Sep 2009	£455
KeyNeurotek AG-Company Report	Sep 2009	£455
Kobayashi Pharmaceutical Co., Ltd.-Company Report	Sep 2009	£455
KOBEC Pharmacals-Company Report	Sep 2009	£455
Kontest Chemicals Limited-Company Report	Sep 2009	£455
Korea Vaccine Co., Ltd.-Company Report	Sep 2009	£455
Kitasato Institute Research Center for Biologicals-Company Report	Sep 2009	£455
Kissei Pharmaceutical Co., Ltd.-Company Report	Sep 2009	£455
Kiadis Pharma B.V.-Company Report	Sep 2009	£455
Kilitch Drugs (India) Ltd.-Company Report	Sep 2009	£455
Kinex Pharmaceuticals, LLC-Company Report	Sep 2009	£455
KIPA Pharmacal Ltd-Company Report	Sep 2009	£455
Laboratorio Teuto-Company Report	Sep 2009	£455
Laboratorio Elea SACIFYA-Company Report	Sep 2009	£455
Lipocine Inc.-Company Report	Sep 2009	£455
LiPlasome Pharma A/S-Company Report	Sep 2009	£455
Lipomed AG-Company Report	Sep 2009	£455
Lipoxen-Company Report	Sep 2009	£455
Living Cell Technologies Ltd-Company Report	Sep 2009	£455
Lipicard Technologies Limited-Company Report	Sep 2009	£455
Lion Corporation-Company Report	Sep 2009	£455
LifeTec Group Limited-Company Report	Sep 2009	£455
Light Sciences Oncology, Inc.-Company Report	Sep 2009	£455
LigoCyte Pharmaceuticals, Inc.-Company Report	Sep 2009	£455
Liomont SA de CV-Company Report	Sep 2009	£455
Liqvor CJSC-Company Report	Sep 2009	£455
LIVZON Pharmaceutical Group Inc.-Company Report	Sep 2009	£455
Lupin Ltd-Company Report	Sep 2009	£455
Lux Biosciences, Inc.-Company Report	Sep 2009	£455
Lyka Labs Limited-Company Report	Sep 2009	£455
Lytix Biopharma AS-Company Report	Sep 2009	£455
Lumen Therapeutics-Company Report	Sep 2009	£455
Luitpold Pharmaceuticals, Inc.-Company Report	Sep 2009	£455
Locus Pharmaceuticals, Inc.-Company Report	Sep 2009	£455
Logical Therapeutics, Inc.-Company Report	Sep 2009	£455
Lotus Pharmaceutical Co., Ltd.-Company Report	Sep 2009	£455
LTT Bio-Pharma Co., Ltd-Company Report	Sep 2009	£455
LifeCycle Pharma A/S-Company Report	Sep 2009	£455
LIBBS Farmaceutica Ltd-Company Report	Sep 2009	£455
Laboratorios Phoenix-Company Report	Sep 2009	£455
Laboratorios Zafiro, S.A. de C.V-Company Report	Sep 2009	£455
Laboratorios CINFA-Company Report	Sep 2009	£455
LaborMed Pharma-Company Report	Sep 2009	£455
Labtec GmbH-Company Report	Sep 2009	£455
Laboratorios Salvat, S.A-Company Report	Sep 2009	£455
Laboratorios Manuell, S.A-Company Report	Sep 2009	£455
Laboratorios Almirall, S.A.-Company Report	Sep 2009	£455
Laboratorios Gebro Pharma, S.A.-Company Report	Sep 2009	£455
Laboratorios Grin, S.A. de C.V.-Company Report	Sep 2009	£455
Laboratorios Juventus, S.A.-Company Report	Sep 2009	£455
LACER, S.A.-Company Report	Sep 2009	£455
Lannacher Heilmittel Gmbh-Company Report	Sep 2009	£455
Leuchemix-Company Report	Sep 2009	£455
LeukoMed, Inc.-Company Report	Sep 2009	£455
LFB-Company Report	Sep 2009	£455
LG Life Sciences Ltd.-Company Report	Sep 2009	£455
LEO Pharma A/S-Company Report	Sep 2009	£455
Lentigen Corporation-Company Report	Sep 2009	£455
Lark Laboratories-Company Report	Sep 2009	£455
LAVIPHARM Group-Company Report	Sep 2009	£455
Lawley Pharmaceuticals-Company Report	Sep 2009	£455
Leksir Ltd.-Company Report	Sep 2009	£455
M.J. Group-Company Report	Sep 2009	£455